These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 35465086)
1. The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension. Khatab Y; Ghafouri SR; Alkhateeb H; Mukherjee D; Garcia H; Nickel NP Cardiol Res; 2022 Apr; 13(2):73-80. PubMed ID: 35465086 [TBL] [Abstract][Full Text] [Related]
2. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension. Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349 [TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide is a useful prognostic marker in patients with pre-capillary pulmonary hypertension and renal insufficiency. Harbaum L; Hennigs JK; Baumann HJ; Lüneburg N; Griesch E; Bokemeyer C; Grünig E; Klose H PLoS One; 2014; 9(4):e94263. PubMed ID: 24751887 [TBL] [Abstract][Full Text] [Related]
4. Log-transformation improves the prognostic value of serial NT-proBNP levels in apparently stable pulmonary arterial hypertension. Soon E; Doughty NJ; Treacy CM; Ross RM; Toshner M; Upton PD; Sheares K; Morrell NW; Pepke-Zaba J Pulm Circ; 2011; 1(2):244-9. PubMed ID: 22034610 [TBL] [Abstract][Full Text] [Related]
5. Serial Measurements of N-Terminal Pro-B-Type Natriuretic Peptide Serum Level for Monitoring Pulmonary Arterial Hypertension in Children. Said F; Haarman MG; Roofthooft MTR; Hillege HL; Ploegstra MJ; Berger RMF J Pediatr; 2020 May; 220():139-145. PubMed ID: 32113658 [TBL] [Abstract][Full Text] [Related]
6. Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up. Xanthouli P; Koegler M; Marra AM; Benjamin N; Fischer L; Eichstaedt CA; Harutyunova S; Nagel C; Grünig E; Egenlauf B Respir Res; 2020 May; 21(1):127. PubMed ID: 32448256 [TBL] [Abstract][Full Text] [Related]
7. No changes in N-terminal pro-brain natriuretic peptide in a longitudinal cohort of patients with systemic sclerosis-associated pulmonary arterial hypertension on therapy with bosentan. Rotondo C; Praino E; Nivuori M; di Serio F; Lapadula G; Iannone F Int J Rheum Dis; 2017 Jan; 20(1):90-96. PubMed ID: 26218502 [TBL] [Abstract][Full Text] [Related]
8. Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis. Cavagna L; Caporali R; Klersy C; Ghio S; Albertini R; Scelsi L; Moratti R; Bonino C; Montecucco C J Rheumatol; 2010 Oct; 37(10):2064-70. PubMed ID: 20634241 [TBL] [Abstract][Full Text] [Related]
9. Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry. Chung L; Fairchild RM; Furst DE; Li S; Alkassab F; Bolster MB; Csuka ME; Derk CT; Domsic RT; Fischer A; Frech TM; Gomberg-Maitland M; Gordon JK; Hinchcliff M; Hsu V; Hummers LK; Khanna D; Medsger TAJ; Molitor JA; Preston IR; Schiopu E; Shapiro L; Hant F; Silver R; Simms R; Varga J; Steen VD; Zamanian RT Clin Exp Rheumatol; 2017; 35 Suppl 106(4):106-113. PubMed ID: 27908301 [TBL] [Abstract][Full Text] [Related]
10. N-terminal pro-brain natriuretic peptide as a diagnostic marker of early pulmonary artery hypertension in patients with systemic sclerosis and effects of calcium-channel blockers. Allanore Y; Borderie D; Meune C; Cabanes L; Weber S; Ekindjian OG; Kahan A Arthritis Rheum; 2003 Dec; 48(12):3503-8. PubMed ID: 14674001 [TBL] [Abstract][Full Text] [Related]
11. Baseline NT-proBNP correlates with change in 6-minute walk distance in patients with pulmonary arterial hypertension in the pivotal inhaled treprostinil study TRIUMPH-1. Frantz RP; McDevitt S; Walker S J Heart Lung Transplant; 2012 Aug; 31(8):811-6. PubMed ID: 22759797 [TBL] [Abstract][Full Text] [Related]
12. N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Thakkar V; Stevens WM; Prior D; Moore OA; Byron J; Liew D; Patterson K; Hissaria P; Roddy J; Zochling J; Sahhar J; Nash P; Tymms K; Celermajer D; Gabbay E; Youssef P; Proudman SM; Nikpour M Arthritis Res Ther; 2012 Jun; 14(3):R143. PubMed ID: 22691291 [TBL] [Abstract][Full Text] [Related]
13. The association of the N-terminal pro-brain-type natriuretic peptide response to exercise with disease severity in therapy-naive pulmonary arterial hypertension: a cohort study. Kutsch J; Faul C; von Scheidt W; Schwaiblmair M; Berghaus TM Respir Res; 2018 Jan; 19(1):8. PubMed ID: 29334941 [TBL] [Abstract][Full Text] [Related]
14. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis. David S; Kümpers P; Seidler V; Biertz F; Haller H; Fliser D Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624 [TBL] [Abstract][Full Text] [Related]
16. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study. Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745 [TBL] [Abstract][Full Text] [Related]
17. Correlation Between N-Terminal Pro-Brain Natriuretic Peptide Levels and Cardiopulmonary Exercise Testing in Patients With Pre-Capillary Pulmonary Hypertension: A Pilot Study. Aueyingsak S; Khrisanapant W; Kukongviriyapun U; Pasurivong O; Ratanawatkul P; Wanitpongpan C; Pussadhamma B Clin Med Insights Circ Respir Pulm Med; 2020; 14():1179548420954049. PubMed ID: 33117035 [TBL] [Abstract][Full Text] [Related]
18. The Association Between Non-Clinically Apparent Liver Fibrosis and Pulmonary Arterial Hypertension in Hispanic Patients. Kalas MA; Khatab Y; Galura G; Alkhateeb H; Mukherjee D; Garcia H; Zuckerman M; Nickel NP Cardiol Res; 2023 Dec; 14(6):429-436. PubMed ID: 38187513 [TBL] [Abstract][Full Text] [Related]